MESO Mesoblast Limited Stock Quote

MESO [NASD]

Index	-	P/E	-	EPS (ttm)	-0.89	Insider Own	-	Shs Outstand	116.50M	Perf Week	-6.98%
Market Cap	1.10B	Forward P/E	87.27	EPS next Y	0.11	Insider Trans	-	Shs Float	115.83M	Perf Month	4.69%
Income	-97.00M	PEG	-	EPS next Q	-0.21	Inst Own	2.90%	Short Float	2.44%	Perf Quarter	-18.58%
Sales	16.40M	P/S	67.28	EPS this Y	18.90%	Inst Trans	1.68%	Short Ratio	3.36	Perf Half Y	-45.79%
Book/sh	4.62	P/B	2.08	EPS next Y	133.30%	ROA	-13.80%	Target Price	14.96	Perf Year	4.12%
Cash/sh	0.94	P/C	10.22	EPS next 5Y	48.80%	ROE	-18.70%	52W Range	3.12 - 21.28	Perf YTD	13.07%
Dividend	-	P/FCF	-	EPS past 5Y	13.10%	ROI	-9.80%	52W High	-54.89%	Beta	3.74
Dividend %	-	Quick Ratio	1.30	Sales past 5Y	10.20%	Gross Margin	-	52W Low	207.68%	ATR	0.52
Employees	102	Current Ratio	1.30	Sales Q/Q	-92.40%	Oper. Margin	-	RSI (14)	44.49	Volatility	4.70% 4.94%
Optionable	Yes	Debt/Eq	0.19	EPS Q/Q	-283.80%	Profit Margin	-	Rel Volume	0.34	Prev Close	9.53
Shortable	Yes	LT Debt/Eq	0.12	Earnings	-	Payout	-	Avg Volume	839.71K	Price	9.60
Recom	2.40	SMA20	-2.96%	SMA50	-5.57%	SMA200	-25.62%	Volume	283,504	Change	0.73%

Dec-22-20

Downgrade

Maxim Group

Buy → Hold

Dec-04-20

Downgrade

Chardan Capital Markets

Neutral → Sell

$7.50

Oct-22-20

Initiated

RBC Capital Mkts

Sector Perform

$12

Aug-14-20

Reiterated

Maxim Group

Buy

$16 → $22

May-28-20

Reiterated

H.C. Wainwright

Buy

$14 → $21

Jan-31-19

Resumed

H.C. Wainwright

Buy

$6.50

Mar-22-18

Downgrade

Credit Suisse

Neutral → Underperform

Feb-28-18

Reiterated

Cantor Fitzgerald

Buy

$20 → $23

Aug-31-17

Initiated

Oppenheimer

Outperform

$16

Jun-08-17

Initiated

Cantor Fitzgerald

Buy

Feb-17-21 06:00AM	Positive Outcomes of First Children Treated With Remestemcel-L for Multisystem Inflammatory Syndrome (MIS-C) and Heart Failure Post-COVID-19 Published in Pediatrics GlobeNewswire
Feb-11-21 01:32PM	Why Mesoblast Limited Is Rising Today Motley Fool +10.49%
05:41AM	Mesoblast Spikes On Positive Cell Therapy Data in Back Pain Study Benzinga
Feb-10-21 06:42PM	Mesoblast Phase 3 Trial Shows That a Single Injection of Rexlemestrocel-L + Hyaluronic Acid Carrier Results in at Least Two Years of Pain Reduction With Opioid Sparing Activity in Patients With Chronic Low Back Pain Due to Degenerative Disc Disease GlobeNewswire
05:35PM	Mesoblast Corporate Update GlobeNewswire
Jan-28-21 07:05PM	Mesoblast Operational and Financial Highlights for Quarter Ended December 31, 2020 GlobeNewswire
Jan-26-21 11:24AM	How Much Of Mesoblast Limited (ASX:MSB) Do Insiders Own? Simply Wall St.
Jan-12-21 09:32AM	Company News for Jan 12, 2021 Zacks -10.18%
08:48AM	Is the Options Market Predicting a Spike in Mesoblast (MESO) Stock? Zacks
Jan-11-21 05:10PM	Mesoblast Presents Heart Failure Phase 3 Trial Results at Investor Healthcare Conference GlobeNewswire +31.64%
04:43PM	Why Mesoblast Stock Skyrocketed Today Motley Fool
Jan-10-21 11:26PM	Single Dose of Rexlemestrocel-L Provides Substantial and Durable Reduction in Heart Attacks, Strokes and Cardiac Death in Patients With Chronic Heart Failure GlobeNewswire
Dec-21-20 09:47AM	Analysts Are More Bearish On Mesoblast Limited (ASX:MSB) Than They Used To Be Simply Wall St. -7.34%
Dec-18-20 04:46PM	Why Mesoblast Stock Plummeted on Friday Motley Fool -31.69%
Dec-17-20 10:07PM	Mesoblast Webcast Update on COVID-19 ARDS Trial GlobeNewswire
06:32PM	Mesoblast Update on COVID-19 ARDS Trial GlobeNewswire
Dec-15-20 12:56PM	Why Mesoblast Stock Is Tanking Today Motley Fool -19.66%
Dec-14-20 05:27PM	Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure GlobeNewswire
04:56PM	Mesoblast Corporate Update GlobeNewswire
Dec-08-20 09:12AM	Implied Volatility Surging for Mesoblast (MESO) Stock Options Zacks
08:15AM	Lawsuit for Investors in shares of Mesoblast Limited (OTC: MEOBF) announced by Shareholders Foundation ACCESSWIRE
Dec-07-20 04:33PM	MESO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 7, 2020 in the Class Action Filed on Behalf of Mesoblast Limited Limited Shareholders Newsfile
03:00PM	MESO Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Deadline: December 7, 2020 ACCESSWIRE
01:30PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MESO, LOOP and LVS ACCESSWIRE
12:45PM	FINAL DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $50,000 to Contact the Firm ACCESSWIRE
10:12AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Mesoblast Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2020 - MESO Newsfile
10:05AM	DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
10:00AM	MESO Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020 GlobeNewswire
08:42AM	MESO Final Deadline Today: Rosen, Leading Trial Attorneys, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action - MESO Newsfile
06:20AM	CLASS ACTION UPDATE for MESO, TRQ and BRY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
06:00AM	Remestemcel-L Reduces Inflammatory Biomarkers Predictive of High Mortality in Acute Graft Versus Host Disease GlobeNewswire
12:20AM	FINAL DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Dec-06-20 12:30PM	MESO FINAL MONDAY DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mesoblast Limited Investors Seek Counsel Before Important December 7 Deadline in Securities Class Action MESO ACCESSWIRE
Dec-05-20 06:32PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline - MESO PR Newswire
10:45AM	MESO FINAL DEADLINE MONDAY: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action MESO Business Wire
Dec-04-20 09:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Mesoblast Limited and Encourages Investors to Contact the Firm Business Wire
12:15PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of RCL, MESO and PINS ACCESSWIRE
11:00AM	MESO Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020 Business Wire
09:39AM	DEADLINE MONDAY ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
09:30AM	Lawsuits Filed Against MESO, LVS and YY - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
08:00AM	Mesoblast Limited Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm GlobeNewswire
Dec-03-20 07:10PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RCL, MESO and LVS ACCESSWIRE
06:45PM	MESO FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action MESO GlobeNewswire
02:15PM	SHAREHOLDER ALERT: MESO TRQ YY: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
01:00PM	MESO Deadline Reminder: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020 ACCESSWIRE
11:00AM	CLASS ACTION UPDATE for RCL, MESO and LVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
09:33AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Dec-02-20 11:24AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Mesoblast Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2020 - MESO Newsfile
11:00AM	MESO Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Mesoblast Limited Investors of Class Action and Lead Plaintiff Deadline: December 7, 2020 Newsfile
09:38AM	MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
06:00AM	FDA Grants Fast Track Designation for Remestemcel-L in the Treatment of Acute Respiratory Distress Syndrome Due to COVID-19 GlobeNewswire
Dec-01-20 09:40PM	SHAREHOLDER ALERT: RCL MESO LVS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
09:00PM	DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Mesoblast Limited and Encourages Investors to Contact the Firm GlobeNewswire
06:30PM	CLASS ACTION UPDATE for MESO, LOOP and RTX: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
05:55PM	Rosen, Top Ranked Investor Counsel, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESO Newsfile
11:30AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, TRQ and LVS ACCESSWIRE
11:15AM	DEADLINE ALERT for MESO and RCL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:00AM	PGEN, MESO & LOOP Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm GlobeNewswire
10:10AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of RCL, MESO and FAF ACCESSWIRE
09:20AM	MONDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Mesoblast Limited and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Nov-30-20 01:52PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of MESO, LOOP and TILE ACCESSWIRE
01:00PM	PGEN, MESO & LOOP Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
12:30PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MESO, BABA and PINS ACCESSWIRE
12:00PM	DEADLINE ALERT for RCL, MESO, LOOP, TRQ: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
06:30AM	LAWSUITS FILED AGAINST MESO, FAF and BRY - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
Nov-29-20 01:00PM	PGEN, MESO & LOOP Class Action Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
Nov-28-20 11:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline MESO ACCESSWIRE
02:00PM	ROSEN, RESPECTED INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESO PR Newswire
Nov-27-20 01:07PM	Where Do Hedge Funds Stand On Mesoblast Limited (MESO)? Insider Monkey
01:00PM	MESO INDIVIDUAL INVESTOR ALERT: ROSEN, INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action - MESO ACCESSWIRE
Nov-26-20 09:03AM	Analysts Just Made A Stunning Upgrade To Their Mesoblast Limited (ASX:MSB) Forecasts Simply Wall St.
06:20AM	SHAREHOLDER ALERT: CACC MESO HPQ: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Nov-25-20 10:23PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline MESO GlobeNewswire -8.72%
11:35AM	CLASS ACTION UPDATE for MESO, LOOP and BIIB: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM	PGEN, MESO & LOOP Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm GlobeNewswire
Nov-24-20 08:28PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Mesoblast Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2020 - MESO Newsfile +5.88%
07:00PM	ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm MESO GlobeNewswire
04:25PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MESO, TILE and YY ACCESSWIRE
04:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Royal Caribbean, Mesoblast, Loop Industries, and Turquoise Hill Resources and Encourages Investors to Contact the Firm GlobeNewswire
01:35PM	CLASS ACTION UPDATE for TCMD, MESO and FAF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
01:00PM	PGEN, MESO & LOOP Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
12:00PM	Lawsuits Filed Against CACC, RCL and MESO - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
11:30AM	DEADLINE ALERT for MESO and RCL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
06:20AM	SHAREHOLDER ALERT: MESO FAF LRN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Nov-23-20 11:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Law Suit and Upcoming Deadline MESO ACCESSWIRE +14.73%
01:27PM	MESO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 7, 2020 in the Class Action Filed on Behalf of Mesoblast Limited Limited Shareholders Newsfile
01:10PM	MESO LARGE LOSS ALERT: ROSEN, GLOBAL ATTORNEYS, Encourages Mesoblast Limited Investors with Large Losses to Seek Counsel Before Important Deadline in Securities Class Action - MESO ACCESSWIRE
12:00PM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mesoblast Limited (MESO) GlobeNewswire
11:45AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MESO, LOOP and LRN ACCESSWIRE
11:00AM	PGEN, MESO & LOOP Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Encourages Investors to Contact the Firm ACCESSWIRE
06:25AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Mesoblast Limited of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 7, 2020 - MESO Newsfile
Nov-22-20 12:32AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mesoblast Limited of Class Action Lawsuit and Upcoming Deadline MESO GlobeNewswire
Nov-21-20 01:06PM	LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors with Losses in Excess of $100,000 to Contact the Firm PR Newswire
Nov-20-20 07:06PM	ROSEN, A TOP RANKED FIRM, Reminds Mesoblast Limited Investors of Important December 7 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - MESO Newsfile +16.88%
11:20AM	Why Mesoblast Stock Is Blasting Off Today Motley Fool
10:17AM	Novartis (NVS) Partners With Mesoblast for ARDS Cell Therapy Zacks
Nov-19-20 05:40PM	LAWSUITS FILED AGAINST BTU, CACC and MESO - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
05:36PM	Operational and Financial Results for the Period Ended September 30, 2020 GlobeNewswire
05:21PM	ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Reminds Mesoblast Limited Investors of Important Deadline in Securities Class Action MESO GlobeNewswire
05:12PM	Mesoblast Enters Global Collaboration for Development, Manufacture and Commercialization of Remestemcel-L GlobeNewswire

Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. The company's products under the Phase III clinical trials include MSC-100-IV for steroid refractory acute graft versus host disease; MPC-150-IM for advanced heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV that is in Phase II clinical trials for the treatment of biologic refractory rheumatoid arthritis, diabetic kidney diseases, and type 2 diabetic nephropathy. It operates in the United States, Australia, Singapore, the United Kingdom, and Switzerland. Mesoblast Limited has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. for the treatment of wound healing in patients with epidermolysis bullosa; and Grunenthal to develop and commercialize cell therapy for the treatment of chronic low back pain. The company was founded in 2004 and is headquartered in Melbourne, Australia.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience